Rising ACA Costs Leave Many Unable To Pay for Coverage

Higher health insurance costs are forcing some people to walk away from coverage even after signing up.

About 14% of people who enrolled in Affordable Care Act (ACA) plans for 2026 did not pay their first monthly premium, according to a new analysis from Wakely Consulting Group, an actuarial firm.

That’s much higher than the usual early-year drop-off, which is typically in the mid-single digits.

“It’s a big drop,” Michelle Anderson, a consulting actuary at Wakely, told The Wall Street Journal.

It likely owes to premium hikes following expiration of expanded federal subsidies introduced during the pandemic.

Enrollment was already slipping, falling to 23 million in 2026 from more than 24 million last year. Millions more could lose coverage if they don’t make payments within a three-month grace period, The Wall Street Journal reported.

Some patients say the cost increases left them with limited options.

Sarah Smith, a 53-year-old office manager in Ohio, said her monthly premium jumped from about $150 last year to roughly $700 after losing her subsidy. Her ACA policy also covered her 20-year-old son.

She decided to buy a cheaper short-term policy instead, even though it offers less protection.

“I try not to think about it,” Smith told The Wall Street Journal. “Knock on wood, hope that he’s OK, I’m OK,” she said, referring to herself and her now uninsured son.

Others are going without insurance entirely. Sharon Dunham, a 63-year-old cancer survivor, said her monthly premium would have risen to about $980, up from $614 last year.

“It is definitely terrifying,” she told The Wall Street Journal. “There’s the very real possibility that I can’t do anything if it shows up.”

Experts say rising costs can change who stays insured. Younger, more healthier people are more likely to drop coverage.

Wakely’s data showed that people who paid their initial premiums in 2026 were about 10% less healthy, based on their expected medical costs, than those who did not pay at all.

That shift could lead to higher premiums in the future, as insurers raise prices to cover increased costs.

The impact varies by state. Some states saw higher rates of people not paying, especially those using HealthCare.gov.

In Arizona, Blue Cross Blue Shield reported losing more than 30% of its ACA enrollees for 2026 due to non payments, compared with 2% last year.

“It is simply because the cost of health insurance is more than what they can afford,” CEO Pam Kehaly said.

Wakely estimates that ACA enrollment could drop by 17% to 26% this year compared to 2025.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square